Health for all, Hunger for none

拜耳中国

About Bayer
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Innovation
Innovation plays an important role in overcoming global challenges and is a key driver of future growth at Bayer.
- Innovation
- Inventive talent
Products
With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition.
Sustainability
Read more about our economic, ecological and social challenges and opportunities.
- Motivation
- Sustainability
CSR
As a highly socially responsible company, the Bayer Group for its operations around the world to fulfill its responsibility as a corporate citizen.
- CSR
- Bayer China Volunteer Platform
  
  Delivering Health Concept
  
  Promoting Social Integration
  
  Science Education in Community
  
  Protecting the Environment
Media
This area provides news and publications.
- All News
- Press Contacts
Career
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
- Career

ALL News

45newscente

News context

News Area (field_news_area)

News Topic (field_news_topic)

Country

Internal Listing Title (field_listing_title)

5b90d94075bb1

August 21, 2021

Bayer starts Phase III clinical development program OASIS with Elinzanetant

5b90d94075bb1

August 05, 2021

Second quarter of 2021

5b90d94075bb1

May 12, 2021

Bayer: successful start to 2021

5b90d94075bb1

February 25, 2021

Bayer delivers robust performance despite pandemic – foundation laid for future growth

bayer-nutrient-gap-initiative

February 02, 2021

Bayer launches The Nutrient Gap Initiative to Expand Access to Vitamins and Minerals for 50 Million People Annually Worldwide by 2030

5b90d94075bb1

December 07, 2020

CDP rating: Bayer leads in sustainability

5b90d94075bb1

November 03, 2020

Challenging third quarter – Group outlook confirmed

edeecadac5260901c22ce34e9707f53

August 17, 2020

Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China